Acylcarnitines in intermediary metabolism

This publication has 49 references indexed in Scilit:

• L-carnitine: a way to decrease cellular toxicity of ifosfamide?
  European Journal of Pediatrics, 1995
• L-carnitine: a way to decrease cellular toxicity of ifosfamide?
  European Journal of Pediatrics, 1995
• Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A severe fatty acid oxidation disorder
  European Journal of Pediatrics, 1994
• Identification of phenylpropionylcarnitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl‐coa dehydrogenase deficiency
  Journal of Inherited Metabolic Disease, 1990
• Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases
  The American Journal of Cardiology, 1990
• Simple and unambiguous method for identifying urinary acylcarnitines using gas chromatography-mass spectrometry
  The Analyst, 1990
• Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: Effect of metabolic state and l-carnitine therapy
  The Journal of Pediatrics, 1989
• Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency.
  Journal of Clinical Investigation, 1986
• Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids
  The Journal of Pediatrics, 1985
• Tissue levels of acid-insoluble carnitine in rat heart
  Biochimica et Biophysica Acta (BBA) - Specialized Section on Lipids and Related Subjects, 1964